Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
06896 GOLDEN THROAT
1.740
-0.060-3.33%
YOY
Do not show
Hide blank lines
(Q6)2022/06/30(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31
Turnover
-16.39% 312.11M 26.83% 820.54M 83.06% 373.29M -18.84% 646.94M
Operating income
-16.39% 312.11M 26.83% 820.54M 83.06% 373.29M -18.84% 646.94M
Cost of sales
12.94% -85.05M -41.75% -242.81M -89.28% -97.68M 13.78% -171.3M
Operating expenses
12.94% -85.05M -41.75% -242.81M -89.28% -97.68M 13.78% -171.3M
Gross profit
-17.61% 227.07M 21.46% 577.74M 80.95% 275.61M -20.52% 475.64M
Selling expenses
19.36% -119.26M -3.28% -261.61M -38.67% -147.89M 17.88% -253.31M
Administrative expenses
21.09% -36.82M -23.53% -103.18M -61.13% -46.66M -7.72% -83.53M
Special items of operating profit
-52.84% 9.2M -49.07% 31.87M 58.34% 19.51M 262.62% 62.58M
Operating profit
-20.26% 80.19M 21.57% 244.82M 246.47% 100.56M -12.34% 201.39M
Financing cost
-54.60% -4.55M 30.67% -7.98M 53.49% -2.94M -17.29% -11.5M
Earning before tax
-22.52% 75.64M 24.73% 236.85M 330.08% 97.62M -13.66% 189.89M
Tax
-17.37% -18.91M -37.31% -49.2M -134.83% -16.11M 31.49% -35.83M
After-tax profit from continuing operations
-30.40% 56.73M 21.80% 187.64M 414.65% 81.51M -8.09% 154.05M
Earning after tax
-30.40% 56.73M 21.80% 187.64M 414.65% 81.51M -8.09% 154.05M
Profit attributable to shareholders
-30.40% 56.73M 21.80% 187.64M 414.65% 81.51M -8.09% 154.05M
Basic earnings per share
-27.27% 0.08 21.79% 0.2538 450.00% 0.11 -8.07% 0.2084
Diluted earnings per share
-27.27% 0.08 21.79% 0.2538 450.00% 0.11 -8.07% 0.2084
Currency Unit
CNYCNYCNYCNY
Accounting Standards
HKASHKASHKASHKAS
Audit Opinions
--Unqualified Opinion--Unqualified Opinion
Auditor
--Ernst & Young accounting firm--Ernst & Young accounting firm

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Golden throat Holdings Group Limited (the "Company", together with its subsidiaries known as "the Group" or "Golden throat") is a leading manufacturer of throat moisturizing tablets in China. In the comprehensive statistical evaluation of Chinese over-the-counter drug enterprises and product brands in 2021, Golden throat tablet (OTC) stood out among many product brands and won the first place in the throat category of Chinese patent medicine by the China over-the-counter Drug Association, and ranked 43rd in the comprehensive ranking of over-the-counter drug manufacturers. Won the honor of top 500 Chinese brands at the 14th China Brand Festival in August 2020 and the honor of "2019 Top 100 Enterprises of traditional Chinese Medicine in China Pharmaceutical Industry" at the annual meeting of the Top 100 Chinese Pharmaceutical Industry in August 2020! The history of the Group can be traced back to 1956, when Liuzhou Confectionery No.2 Factory, the predecessor of Guangxi Golden throat Co., Ltd. (an indirect wholly-owned subsidiary of the Company), was established. The Company was incorporated as an exempted limited company in the Cayman Islands on September 2, 2014. The shares of the Company were listed on the main board of the Stock Exchange of Hong Kong Limited on 15 July 2015 (the "listing date"). Today, the Group has developed into a modern integrated group, mainly engaged in the production and sale of throat moistening tablets and other medicines and foodstuffs.
CEO: Peizhen Jiang
Market: Hong Kong motherboard
Listing Date: 07/15/2015
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist